High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: The French ANRS CO06 PRIMO Cohort Study

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 135-141

  Frange, Pierre ^a,b   Galimand, Julie ^a   Goujard, Cécile ^c   Deveau, Christiane ^d   Ghosn, Jade ^a,c   Rouzioux, Christine ^a   Meyer, Laurence ^d   Chaix, Marie Laure ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c BICÊTRE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

Co receptors; CXCR4 virus; Genotypic algorithm; Primary infection

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; VIRUS DNA; VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIMARY INFECTION; RISK FACTOR; VIROGENESIS; VIRUS CLASSIFICATION; VIRUS IDENTIFICATION; VIRUS RESISTANCE; VIRUS STRAIN;

COHORT STUDIES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RECEPTORS, HIV; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRUS ATTACHMENT;

EID: 67249147641     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp151     Document Type: Article

References (39)

1. Moore JP, Kitchen SG, Pugach P et al. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20: 111-26.
2. Bomsel M, David V. Mucosal gatekeepers: Selecting HIV viruses for early infection. Nat Med 2002; 8: 114-6.
3. Zhu T, Mo H, Wang N et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261: 1179-81.
4. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657-700.
5. Moyle GJ, Wildfire A, Mandalia S et al. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. J Infect Dis 2005; 191: 866-72.
6. Koot M, Keet IP, Vos AH et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118: 681-8.
7. Maas JJ, Gange SJ, Schuitemaker H et al. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study. AIDS 2000; 14: 1155-61.
8. Shepherd JC, Jacobson LP, Qiao W et al. Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multi-center AIDS cohort study. J Infect Dis 2008; 198: 1104-12.
9. Weiser B, Philpott S, Klimkait T et al. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. AIDS 2008; 22: 469-79.
10. Whitcomb JM, Huang W, Fransen S et al. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother 2007; 51: 566-75.
11. Low AJ, Dong W, Chan D et al. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. AIDS 2007; 21: F17-24.
12. de Mendoza C, Van Baelen K, Poveda E et al. Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters. J Acquir Immune Defic Syndr 2008; 48: 241-4.
13. Raymond S, Delobel P, Mavigner M et al. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS 2008; 22: F11-6.
14. Skrabal K, Low AJ, Dong W et al. Determining human immuno-deficiency virus coreceptor use in a clinical setting: Degree of correlation between two phenotypic assays and a bioinformatic model. J Clin Microbiol 2007; 45: 279-84.
15. de Mendoza C, Rodriguez C, Garcia F et al. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. J Antimicrob Chemother 2007; 59: 698-704.
16. Eshleman SH, Husnik M, Hudelson S et al. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS 2007; 21: 1165-74.
17. Goujard C, Bonarek M, Meyer L et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006; 42: 709-15.
18. Pasquier C, Millot N, Njouom R et al. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001; 94: 45-54.
19. Delwart EL, Shpaer EG, Louwagie J et al. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993; 262: 1257-61.
20. Thompson JD, Gibson TJ, Plewniak F et al. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-82.
21. Page RD. TreeView: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996; 12: 357-8.
22. de Jong JJ, Goudsmit J, Keulen W et al. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 1992; 66 757-65.
23. Fouchier RA, Brouwer M, Broersen SM et al. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Microbiol 1995; 33: 906-11.
24. Cardozo T, Kimura T, Philpott S et al. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses 2007; 23: 415-26.
25. Delobel P, Nugeyre MT, Cazabat M et al. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J Clin Microbiol 2007; 45: 1572-80.
26. Jensen MA, van't Wout AB. Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 2003; 5: 104-12.
27. Beerenwinkel N, Sing T, Lengauer T et al. Computational methods for the design of effective therapies against drug resistant HIV strains. Bioinformatics 2005; 21: 3943-50.
28. Sing T, Low AJ, Beerenwinkel N et al. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther 2007; 12: 1097-106.
29. Brumme ZL, Goodrich J, Mayer HB et al. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. J Infect Dis 2005; 192: 466-74.
30. Hunt PW, Harrigan PR, Huang W et al. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis 2006; 194: 926-30.
31. Ghosn J, Pellegrin I, Goujard C et al. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time. AIDS 2006; 20: 159-70.
32. Verhofstede C, Vandekerckhove L, Eygen VV et al. CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA. J Acquir Immune Defic Syndr 2009; 50: 126-36.
33. Waters L, Mandalia S, Randell P et al. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen. Clin Infect Dis 2008; 46: 1617-23.
34. Saracino A, Monno L, Punzi G et al. HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples. Virus Res 2007; 130: 34-42.
35. Garrido C, Roulet V, Chueca N et al. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immuno-deficiency virus type 1 subtypes. J Clin Microbiol 2008; 46: 887-91.
36. Huang W, Eshleman SH, Toma J et al. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: High prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 2007; 81: 7885-93.
37. Moores A, Thielen A, Dong W et al. Improved detection of X4 virus by V3 genotyping: Application to plasma RNA and proviral DNA. In: Abstracts of the Seventeenth International HIV Drug Resistance Workshop, Sitges, Spain, 2008. Abstract 89. Antivir Ther 2008; 13 Suppl 3: A99.
38. Recordon-Pinson P, Soulie C, Anies G et al. Evaluation of the genotypic prediction of HIV-1 coreceptor tropism in a clinical setting. In: Abstracts of the Seventeenth International HIV Drug Resistance Workshop, Sitges, Spain, 2008. Abstract 103. Antivir Ther 2008; 13 Suppl 3: A113.
39. Delwart E, Magierowska M, Royz M et al. Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 2002; 16: 189-9